Travel related histoplasmosis – a diagnostic challenge in a patient with tumor necrosis factor alpha (TNF-α) inhibitor therapy

Travel related histoplasmosis – a diagnostic challenge in a patient with tumor necrosis factor alpha (TNF-α) inhibitor therapy

Abstract Introduction In a non-endemic setting, disseminated histoplasmosis is a rare travel-related health problem of immunosuppressed returnees from endemic regions. Methods We describe the case of a 68-year-old man with rheumatoid arthritis and tumor necrosis factor alpha (TNF-α) inhibitor treatm...

Full description

Bibliographic Details
Main Authors: Eveline Hofmann, Konrad Mühlethaler, Matthias Pollak, Daniel Ott, Nora Bienz, Stefan Zimmerli, Cédric Hirzel
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Tropical Diseases, Travel Medicine and Vaccines
Subjects:
Histoplasmosis
Immunocompromised
TNF-α inhibitor
Returning traveler
Hemophagocytic lymphohistiocytosis
Online Access:https://doi.org/10.1186/s40794-022-00178-2

Internet

https://doi.org/10.1186/s40794-022-00178-2

Similar Items